首页> 外文OA文献 >Experience with obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma

【2h】

Experience with obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma

机译：对奥巴替洛克克斯甲磺酸盐（GX15-070）的经验，一只小分子Pan-Bcl-2家庭拮抗剂，患者复发或难治性古典霍奇金淋巴瘤

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Yasuhiro Oki; Amanda Copeland; Fredrick Hagemeister; Luis E. Fayad; Michelle Fanale; Jorge Romaguera; Anas Younes;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Experience with obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma [J] . OkiY., CopelandA., HagemeisterF., Blood: The Journal of the American Society of Hematology . 2012 ,第9期

机译：甲氨蝶呤obatoclax（GX15-070），一种小分子泛Bcl-2家族拮抗剂，在复发性或难治性经典霍奇金淋巴瘤患者中的经验
2. Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis. [J] . Parikh SA, Kantarjian H, Schimmer A, Clinical lymphoma, myeloma & leukemia . 2010 ,第4期

机译：甲磺酸obatoclax（GX15-070）（一种小分子BCL-2家庭拮抗剂）用于患有骨髓纤维化的患者的II期研究。
3. Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia. [J] . OBrien SM, Claxton DF, Crump M, Blood: The Journal of the American Society of Hematology . 2009 ,第2期

机译：甲磺酸奥贝托克（GX15-070）（一种小分子泛Bcl-2家族拮抗剂）在晚期慢性淋巴细胞性白血病患者中进行的I期研究。
4. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
5. Clinical Trials and Observations: Phase I study of obatoclax mesylate (GX15-070) a small molecule pan–Bcl-2 family antagonist in patients with advanced chronic lymphocytic leukemia [O] . Susan M. OBrien, David F. Claxton, Michael Crump, -1

机译：临床试验和观察：甲磺酸奥马托克酯（GX15-070）一种小分子pan-Bcl-2家族拮抗剂用于晚期慢性淋巴细胞性白血病患者的I期研究
6. A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma [O] . André Goy, Francisco J. Hernandez-Ilzaliturri, Brad Kahl, 2014

机译：PAN BCL-2抑制剂Obatoclax甲磺酸盐加上Bortezomib的相I / II研究用于复发或难治性搭腔细胞淋巴瘤

Experience with obatoclax mesylate (GX15-070), a small molecule pan–Bcl-2 family antagonist in patients with relapsed or refractory classical Hodgkin lymphoma

著录项

相似文献

相关主题

期刊订阅